1. Home
  2. FOLD vs KLIC Comparison

FOLD vs KLIC Comparison

Compare FOLD & KLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

N/A

Current Price

$11.00

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Logo Kulicke and Soffa Industries Inc.

KLIC

Kulicke and Soffa Industries Inc.

N/A

Current Price

$45.87

Market Cap

2.4B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
FOLD
KLIC
Founded
2002
1951
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.4B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
FOLD
KLIC
Price
$11.00
$45.87
Analyst Decision
Buy
Strong Buy
Analyst Count
7
3
Target Price
$30.29
$46.67
AVG Volume (30 Days)
5.3M
775.2K
Earning Date
11-04-2025
02-03-2026
Dividend Yield
N/A
1.75%
EPS Growth
N/A
N/A
EPS
N/A
0.00
Revenue
$598,704,000.00
$654,081,000.00
Revenue This Year
$21.49
$20.77
Revenue Next Year
$18.25
$8.23
P/E Ratio
N/A
$11,692.50
Revenue Growth
21.28
N/A
52 Week Low
$5.51
$26.63
52 Week High
$11.14
$52.08

Technical Indicators

Market Signals
Indicator
FOLD
KLIC
Relative Strength Index (RSI) 79.64 55.52
Support Level $9.73 $47.50
Resistance Level $11.14 $49.69
Average True Range (ATR) 0.36 1.65
MACD 0.09 -0.17
Stochastic Oscillator 91.14 25.00

Price Performance

Historical Comparison
FOLD
KLIC

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About KLIC Kulicke and Soffa Industries Inc.

Kulicke & Soffa Industries Inc. is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments, which include Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.

Share on Social Networks: